Implementation and pharmacoeconomic analysis of a clinical staff pharmacist practice model
Implementation and pharmacoeconomic analysis of a clinical staff pharmacist practice model
复制标题
DOI：
10.1093/ajhp/58.9.784
复制
发表时间：
2001-05-01
影响因子：
2.7
通讯作者：
Kvancz, DA
中科院分区：
文献类型：
--
作者：
Nesbit, TW;Shermock, KM;Kvancz, DA
介绍了临床药师工作人员（CSP）实践模式的实施和药物经济学分析。在一个大型三级医疗学术医疗中心选择和培训药师工作人员，在临床药学专家导师的指导下开展临床药学服务。这些CSP从业者的临床干预措施在直接成本节约（治疗之间的实际采购成本差异）和成本避免（避免的药物不良事件[ADE]的美元价值）方面进行了评估。社区服务项目在12个月期间共进行了4959次干预。这些干预措施直接节省费用92 076美元，估计避免费用488 436美元。将成本节约和成本避免与提供这些服务的费用进行比较，表明净经济效益为392，660美元。一种新的药学实践模式，将药剂师纳入现有的临床实践，有可能最大限度地减少风险，降低成本，并改善与药物治疗相关的结果。
The implementation and pharmacoeconomic analysis of a clinical staff pharmacist (CSP) practice model are described.Staff pharmacists at a large, tertiary care, academic medical center were selected and trained to perform clinical pharmacy services under the direction of clinical pharmacy specialist mentors. Clinical interventions by these CSP practitioners were evaluated in terms of direct cost savings (the difference in actual acquisition costs between therapies) and cost avoidance (the dollar value of adverse drug events [ADEs] avoided). The CSPs performed a total of 4959 interventions during a 12-month period. The interventions provided direct cost savings of $92,076 and an estimated cost avoidance of $488,436. Comparing cost savings and cost avoidance with the expenses of providing these services indicated a net economic benefit of $392,660.A new model of pharmacy practice that integrates staff pharmacists into existing clinical practice has the potential to minimize the risks, decrease the costs, and improve the outcomes associated with drug therapy.